Completed

BTEffect of Breathing Circuits on Intraoperative Body Temperature

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Group C

+ Group E

+ Group M

Device
Who is being recruted

Brain Diseases+5

+ Central Nervous System Diseases

+ Neoplasms

From 18 to 70 Years
+6 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Supportive Care Study

Placebo-Controlled
Interventional
Study Start: January 2013
See protocol details

Summary

Principal SponsorSeoul National University Hospital
Last updated: September 17, 2013
Sourced from a government-validated database.Claim as a partner

Study start date: January 1, 2013

Actual date on which the first participant was enrolled.

To evaluate differences in intraoperative body temperature between heated huimid breathing circuit and conventional breathing circuit

NCT01831843
Principal SponsorSeoul National University Hospital
Last updated: September 17, 2013
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

111 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Supportive Care Study

These studies explore ways to improve comfort and daily life for people living with a condition. They may focus on easing symptoms, reducing treatment side effects, or supporting overall well-being.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 70 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Brain DiseasesCentral Nervous System DiseasesNeoplasmsNeoplasms by SiteNervous System DiseasesNervous System NeoplasmsCentral Nervous System NeoplasmsBrain Neoplasms

Criteria

3 inclusion criteria required to participate
ASA I or II
aged 18-70 years
patients scheduled for craniotomy under general anesthesia
3 exclusion criteria prevent from participating
ASA III or IV
Duration of anesthesia time less than 4 hours
emergency operation

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

3 intervention groups are designated in this study

33.333% chance of being blinded to the placebo group

Treatment Groups

Group I

Placebo
non-heated, non-humidified conventional breathing circuit was used in group C patient

Group II

Experimental
breathing tube which apply humidity and heat (Evaqua™ Breathing Circuits manufactured by Fischer & Paykel)was used in group E patient

Group III

Experimental
Heated humid tube with a warming device (Mega Acer kit manufactured by Acemedical,Seoul Korea)was used in group M patient

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Seoul National University Hospital

Seoul, South KoreaOpen Seoul National University Hospital in Google Maps
CompletedOne Study Center